NPHC Projected Dividend Yield
Nutra Pharma Corp ( OTCBB : NPHC )Nutra Pharma is a holding company. Co. engages in the acquisition, licensing and commercialization of pharmaceutical products and technologies as well as homeopathic and ethical drugs for the management of pain, neurological disorders, cancer, autoimmune and infectious diseases. Co.'s subsidiary, ReceptoPharm, Inc., has developed four homeopathic drugs for the treatment of pain: Nyloxin® and Nyloxin® Extra Strength, Pet Pain-Away™, and Equine Nyloxin®. Co. also has developed two drug candidates: RPI-78M, to treat neurological diseases and autoimmune diseases; and RPI-MN, to treat viral diseases including Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome and Herpes. 21 YEAR PERFORMANCE RESULTS |
NPHC Dividend History Detail NPHC Dividend News NPHC Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |